Kcentra: Evaluation of BE1116 (4F-PCC) in Patients with Traumatic Injury and Confirmed or Suspected Acute Major Bleeding to Improve Survival

Grants and Contracts Details

StatusActive
Effective start/end date12/1/2312/1/25

Funding

  • CSL Behring LLC: $49,370.00